Clínic Barcelona
Clínic Barcelona
Research
September 9 2024
Researchers from the Clínic-IDIBAPS have coordinated a study that analyses the efficacy of anti-PD-1/PD-L1 immune checkpoint inhibitors (ICIs) combin1
This IDIBAPS programme allows for the recruitment of clinician-scientists seeking to boost their research career.
Dr. Javier Zarranz-Ventura, ophthalmologist at the Clínic and researcher in the IDIBAPS Ocular Inflammation: Clinical and Experimental Studies group,1
A study published in Science reveals that artemisinin, a treatment for malaria, improves the symptoms of women with PCOS. This advance has made it po1